Trastuzumab (or biosimilar) Clinical Trials

2 recruitingDrug

Phase 22

Filters

Status

RecruitingNot yet recruitingEnrolling by invitationActive, not recruiting

Sex

MaleFemale

Your Age

Shows trials you qualify for by age

Phase

Phase 1Phase 2Phase 3Phase 4Early Phase 1Not Applicable

Study Type

InterventionalObservational

Country

United StatesCanadaUnited KingdomAustraliaGermanyFranceSpainItaly

Related Interventions

Pertuzumab35
SHR-A181120
SHR-A210210
9MW282110
Famitinib6
SHR-A19214
SHR-A20092
Taxane Chemotherapy2

Showing 1–2 of 2 trials

Recruiting

Phase 2

Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer

Metastatic Breast CancerAdvanced Breast Cancer

Fudan University160 enrolled1 locationNCT06649331

Recruiting

Phase 2

Neoadjuvant Trastuzumab Deruxtecan (SHR-A1811) + Pertuzumab in HER2+ Breast Cancer

HER2 + Breast Cancer

Shanghai Jiao Tong University School of Medicine50 enrolled1 locationNCT07393425

ClinicalTrialsFinder

Helping patients and researchers find recruiting clinical trials. Updated regularly from ClinicalTrials.gov and ANZCTR.

Browse

Browse Conditions
Browse Drugs
Browse Locations
Browse Institutions
Search Trials
Get Trial Alerts

Resources

Clinical Trial Guides
FAQ
About Us
Contact
ClinicalTrials.gov
ANZCTR

Data Source

Trial data sourced from ClinicalTrials.gov and ANZCTR (Australian New Zealand Clinical Trials Registry)

Updated regularly to reflect the latest trial information

Medical Disclaimer: This site is for informational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before making decisions about participating in a clinical trial. Trial information may change; verify details directly with the trial sponsor or at the relevant registry (ClinicalTrials.gov or ANZCTR).

|

Privacy Policy Terms of Service

Data provided by ClinicalTrials.gov & ANZCTR